Skip to main content

Table 2 Antibiotic susceptibility patterns of V. fluvialis strains

From: The virulence phenotypes and molecular epidemiological characteristics of Vibrio fluvialis in China

Antibiotic

Breakpoints (mg/ml)

Resistance

Sensitivity

  

R (%)

I (%)

S (%)

Ampicillin

S<=8 I=16 R>=32a

12 (27.3)

8 (18.2)

24 (54.5)

Amoxicillin/Clavulanic acid

S<=8/4 I=16/8 R>=32/16b

10 (22.7)

7 (15.9)

27 (61.4)

Cefotaxime

S<=1 I=2 R>=4b

1 (2.3)

6 (13.6)

37 (84.1)

Ceftriaxone

S<=1 I=2 R>=4b

1 (2.3)

6 (13.6)

37 (84.1)

Ceftazidime

S<=4 I=8 R>=16b

0 (0)

0 (0)

44 (100)

Chloramphenicol

S<=8 I=16 R>=32a

0 (0)

0 (0)

44 (100)

Ciprofloxacin

S<=1 I=2 R>=4b

0 (0)

0 (0)

44 (100)

Gentamicin

S<=4 I=8 R>=16b

0 (0)

0 (0)

44 (100)

Nalidixic acid

S<=16 R>=32b

0 (0)

-

44 (100)

Streptomycin

S<16 R>=16d

1 (2.3)

-

43 (97.7)

Sulfamethoxazole

S<=256 R>=512a

11 (25.0)

-

33 (75.0)

Trimethoprim

S<=8 R>=16b

0 (0)

-

44 (100)

Co-trimoxazole

S<=2/38 R>=4/76a

0 (0)

-

44 (100)

Tetracycline

S<=4 I=8 R>=16a

1 (2.3)

0 (0)

43 (97.7)

Azithromycin

S<=2 I=4 R>=8c

12 (27.3)

5 (11.4)

27 (61.3)

  1. aBreakpoints are based on the CLSI standards for V. cholerae.
  2. bBreakpoints refer to the CLSI criteria for Enterobacteriaceae.
  3. cBreakpoint is based on the CLSI standards for C. jejuni.
  4. dBreakpoint refer to the reference [61].
  5. R, resistance; I, intermediate; S, sensitivity.